Terms: = Bone cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK
468 results:
1. Screening for Synergistic Reagents With Pazopanib Against Osteosarcoma Using a Compound Library.
Yada Y; Asanuma K; Kakimto T; Okuno K; Okamoto T; Iino T; Nakamura T; Sudo A
Anticancer Res; 2024 Mar; 44(3):1071-1078. PubMed ID: 38423639
[TBL] [Abstract] [Full Text] [Related]
2. Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory alk-positive NSCLC from a phase II study.
Zheng J; Wang T; Yang Y; Huang J; Feng J; Zhuang W; Chen J; Zhao J; Zhong W; Zhao Y; Zhang Y; Song Y; Hu Y; Yu Z; Gong Y; Chen Y; Ye F; Zhang S; Cao L; Fan Y; Wu G; Guo Y; Zhou C; Ma K; Fang J; Feng W; Liu Y; Zheng Z; Li G; Wang H; Cang S; Wu N; Song W; Liu X; Zhao S; Ding L; Selvaggi G; Wang Y; Xiao S; Wang Q; Shen Z; Zhou J; Zhou J; Zhang L
Cancer Commun (Lond); 2024 Apr; 44(4):455-468. PubMed ID: 38421881
[TBL] [Abstract] [Full Text] [Related]
3. Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift.
Zhang W; Zhang Y; Ouyang WW; Fa Su S; Ma Z; Li QS; Gang Yang W; Xia Chen X; Liu J; Lu B
Cancer Radiother; 2024 Apr; 28(2):152-158. PubMed ID: 38320903
[TBL] [Abstract] [Full Text] [Related]
4. Percutaneous biopsy for the diagnosis, risk stratification, and molecular profiling of neuroblastoma: A single-center retrospective study.
Schoeman S; Bagatell R; Cahill AM; Maris J; Mattei P; Mosse Y; Pogoriler J; Srinivasan A; Acord M
Pediatr Blood Cancer; 2024 Apr; 71(4):e30887. PubMed ID: 38291721
[TBL] [Abstract] [Full Text] [Related]
5. Spine Metastasis Is Associated with the Development of Brain Metastasis in Non-Small-Cell Lung cancer Patients.
Cha HK; Ryu WK; Lee HY; Kim HJ; Ryu JS; Lim JH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256412
[No Abstract] [Full Text] [Related]
6. Pediatric transplant-associated thrombotic microangiopathy health care utilization and implications of eculizumab therapy.
Schoettler ML; Lehmann L; Kao PC; Chen N; Jodele S; Chonat S; Williams KM; London WB; Duncan C; Dandoy C
Blood Adv; 2024 Mar; 8(5):1220-1233. PubMed ID: 38154068
[TBL] [Abstract] [Full Text] [Related]
7. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature.
Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M
Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270
[TBL] [Abstract] [Full Text] [Related]
8. Overcoming BCR::ABL1 dependent and independent survival mechanisms in chronic myeloid leukaemia using a multi-kinase targeting approach.
Busch C; Mulholland T; Zagnoni M; Dalby M; Berry C; Wheadon H
Cell Commun Signal; 2023 Nov; 21(1):342. PubMed ID: 38031192
[TBL] [Abstract] [Full Text] [Related]
9. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
[TBL] [Abstract] [Full Text] [Related]
10. Extranodal NK/T-Cell Lymphoma Predominantly Composed of Anaplastic Cells: A Frequently Misdiagnosed and Highly Aggressive Variant.
Zhong Y; Xie J; Chen J; Ping L; Zang S; Zhang Y; Feng Y; Huang Y
Am J Surg Pathol; 2024 Feb; 48(2):174-182. PubMed ID: 37982454
[TBL] [Abstract] [Full Text] [Related]
11. Efficacy of CD19 directed therapies in patients with relapsed or refractory large b-cell lymphoma relapsing after CD19 directed chimeric antigen receptor T-cell therapy.
Iqbal M; Jagadeesh D; Chavez J; Khurana A; Rosenthal A; Craver E; Epperla N; Li Z; Isufi I; Awan FT; Dholaria BR; Maakaron JE; Sandoval-Sus JD; Mishra R; Saha A; Annunzio K; Bhaskar ST; Sumransub N; Fijalka A; Ivanov SA; Lin Y; Kharfan-Dabaja MA
Bone Marrow Transplant; 2024 Feb; 59(2):211-216. PubMed ID: 37973893
[TBL] [Abstract] [Full Text] [Related]
12. Transformation of NSCLC to SCLC harboring EML4-alk fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review.
Lingling X; Maoxi C; Wei Y; Jieting Z; Yuanyuan Y; Ning X
Lung Cancer; 2023 Dec; 186():107415. PubMed ID: 37907052
[TBL] [Abstract] [Full Text] [Related]
13. A non-small cell lung carcinoma patient responded to crizotinib therapy after alectinib-induced interstitial lung disease.
Sun W; Zheng J; Zhou J; Zhou J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 52(5):583-587. PubMed ID: 37899398
[TBL] [Abstract] [Full Text] [Related]
14. [Three-dimensional-printed hemi-pelvic prosthesis for revision of aseptic loosening or screw fracture of modular hemi-pelvic prosthesis].
Liu X; Luo Y; He X; Wang J; Li Z; Zhang Y; Hu X; Lu M; Tang F; Zhou Y; Min L; Tu C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2023 Oct; 37(10):1183-1189. PubMed ID: 37848311
[TBL] [Abstract] [Full Text] [Related]
15. Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection.
Demirkesen C; Danyeli AE; Yıldız P; Ertekin SS; Yılmaz B; Karahan Sİ; Bahrami A
J Cutan Pathol; 2023 Dec; 50(12):1059-1064. PubMed ID: 37669767
[TBL] [Abstract] [Full Text] [Related]
16. Role of myofibroblasts in oral plasma cell granuloma: Immunohistochemical evaluation of α-SMA and alk in a retrospective study of 30 cases.
Ibrahim MMA
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101595. PubMed ID: 37573967
[TBL] [Abstract] [Full Text] [Related]
17. Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients.
Xie X; Zhou M; Wang L; Wang F; Deng H; Yang Y; Sun N; Li R; Chen Y; Lin X; Liu M; Zhou C
Hum Vaccin Immunother; 2023 Aug; 19(2):2241310. PubMed ID: 37526078
[TBL] [Abstract] [Full Text] [Related]
18. Novel pathological variants of NHP2 affect N-terminal domain flexibility, protein stability, H/ACA Ribonucleoprotein (RNP) complex formation and telomerase activity.
Maliński B; Vertemara J; Faustini E; Ladenvall C; Norberg A; Zhang Y; von Castelmur E; Baliakas P; Tisi R; Cammenga J; Lottersberger F
Hum Mol Genet; 2023 Sep; 32(19):2901-2912. PubMed ID: 37440454
[TBL] [Abstract] [Full Text] [Related]
19. Inflammatory myofibroblastic tumors: recent progress and future of targeted therapy.
Nakano K
Jpn J Clin Oncol; 2023 Oct; 53(10):885-892. PubMed ID: 37394916
[TBL] [Abstract] [Full Text] [Related]
20. Exploring Prognostic Biomarkers of Acute Myeloid Leukemia to Determine Its Most Effective Drugs from the FDA-Approved List through Molecular Docking and Dynamic Simulation.
Alom MM; Faruqe MO; Molla MKI; Rahman MM
Biomed Res Int; 2023; 2023():1946703. PubMed ID: 37359050
[TBL] [Abstract] [Full Text] [Related]
[Next]
